Showing results (1491-1500 of 1,934) with videos related to
Sort By:
Pageof 194
Applied Occupational and Environmental Hygiene|April 11, 2002
A synthetic vitreous fiber (SVF) occupational exposure database: implementing the SVF Health and Safety Partnership ProgramGary E Marchant, Michael A Amen, Christopher H Bullock, et al.Journal of Applied Physiology (Bethesda, Md. : 1985)|February 9, 2018
Body map of regional vs. whole body sweating rate and sweat electrolyte concentrations in men and women during moderate exercise-heat stressLindsay B Baker, Corey T Ungaro, Bridget C Sopeña, et al.Health Care Financing Review|August 3, 2001
A clinically detailed risk information system for costG M Carter, R M Bell, R W Dubois, et al.The Journal of Infectious Diseases|June 22, 2010
Increases in levels of schistosome-specific immunoglobulin E and CD23(+) B cells in a cohort of Kenyan children undergoing repeated treatment and reinfection with Schistosoma mansoniCarla L Black, Erick M O Muok, Pauline N M Mwinzi, et al.Alcoholism, Clinical and Experimental Research|May 7, 2014
Brief prenatal ethanol exposure alters behavioral sensitivity to the kappa opioid receptor agonist (U62,066E) and antagonist (Nor-BNI) and reduces kappa opioid receptor expressionMichael E Nizhnikov, Ricardo M Pautassi, Jenna M Carter, et al.ACS Applied Polymer Materials|August 19, 2022
Three-Dimensional Printable Enzymatically Active PlasticsWilliam H Zhang, Graham J Day, Ioannis Zampetakis, et al.International Journal of Medical Informatics|November 7, 2022
Utopia versus dystopia: Professional perspectives on the impact of healthcare artificial intelligence on clinical roles and skillsYves Saint James Aquino, Wendy A Rogers, Annette Braunack-Mayer, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 15, 2026
Exploring the 89 Zr/ 177 Lu Theranostic Pairing with an Extracellular Matrix Targeted Radiopharmaceutical Against Triple Negative Breast CancerJustin Hachey, Tara D Viray, Sebastian E Carrasco, et al.Archives of Dermatology|August 1, 1991
Cyclosporine in psoriasis treatment. Inhibition of keratinocyte cell-cycle progression in G1 independent of effects on transforming growth factor alpha/epidermal growth factor receptor pathwaysL Khandke, J F Krane, R Ashinoff, et al.American Journal of Pharmaceutical Education|June 22, 2019
Cultural Sensitivity and Global Pharmacy Engagement in Latin America: Argentina, Brazil, Ecuador, Guatemala, and MexicoSally L Haack, Inbal Mazar, Erin M Carter, et al.Pageof 194